Compass Therapeutics, Inc. (CMPX) Marketable Securities, Current USD 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Compass Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from 2021 to 2024.
  • Compass Therapeutics, Inc. Marketable Securities, Current for the quarter ending March 31, 2024 was $133 M, a 10.5% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $133 M -$15.6 M -10.5% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $128 M -$23.4 M -15.4% Dec 31, 2023 10-Q 2024-05-13
Q3 2023 $133 M +$29.2 M +28% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $149 M +$43.7 M +41.3% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $148 M Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $152 M +$152 M Dec 31, 2022 10-K 2024-03-21
Q3 2022 $104 M Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $106 M Jun 30, 2022 10-Q 2022-08-01
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.